26242 Participants Needed

Behavioral Interventions for Cardiovascular Disease

(BETTER P2 Trial)

AF
AL
Overseen ByAdina Lieberman
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Behavioral Interventions for Cardiovascular Disease is an effective treatment?

The available research shows that behavioral interventions, like message framing and financial incentives, can positively influence health behaviors. For example, message framing has been effective in improving self-management activities in patients with diabetes, which suggests it could also help those with cardiovascular disease. Additionally, financial incentives have been used successfully in trials to lower cholesterol levels, indicating potential benefits for heart health. These findings suggest that behavioral interventions can be a useful treatment for cardiovascular disease by encouraging healthier behaviors.12345

What safety data exists for the behavioral interventions for cardiovascular disease?

The provided research does not directly address safety data for the behavioral interventions for cardiovascular disease or the specific treatments mentioned (Framing Method variations, Lynparza, AZD-2281, MK-7339, KU0059436). The studies focus on risk literacy, framing effects on cardiovascular risk, participant knowledge, and communication of trial results, but do not provide safety data for the interventions in question.678910

Is the treatment in the trial 'Behavioral Interventions for Cardiovascular Disease' a promising treatment?

Yes, behavioral interventions are promising for treating cardiovascular disease. They help people change habits like exercise and diet, which can lower the risk of heart problems. These interventions use techniques like setting goals and self-monitoring, making it easier for people to stick to healthier lifestyles.1112131415

What is the purpose of this trial?

Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.

Eligibility Criteria

This trial is for Black and Hispanic individuals with active medical records at the participating site. It aims to improve diversity in cardiovascular disease studies by testing different recruitment strategies.

Inclusion Criteria

Your medical information must be available in the hospital's electronic system.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Recruitment Strategy Testing

Testing different recruitment strategies to increase enrollment of Black and Hispanic individuals in cardiovascular cohort studies

3 weeks

Follow-up

Participants are monitored for enrollment outcomes and trust in medical researchers

3 weeks

Treatment Details

Interventions

  • Framing Method (Appeal to Altruism)
  • Framing Method (Opt-Out)
  • Framing Method (Social Proof or Perceived Scarcity)
  • Incentive Structure
  • Method of Contact
  • Source of Contact
Trial Overview The study tests various methods to boost enrollment of under-represented groups in heart disease trials, including incentive structures, message framing (like social proof or scarcity), opt-out options, contact methods, and appeals to altruism.
Participant Groups
13Treatment groups
Active Control
Group I: RCT #2, Arm #1: Source of Contact, Personal ClinicActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the person's personal clinic.
Group II: RCT #3, Arm #2: Framing Method, Social ProofActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include language about social proof, i.e. information about participation of individuals similar to the person being contacted. For example, the message will include language such as: "Clinical research studies and the development of effective new medications would not have been possible without the participation of thousands of people like you".
Group III: RCT #3, Arm #3: Framing Method, No Appeal to Altruism, No Social ProofActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include no language about appeal to altruism or social proof.
Group IV: RCT #4, Arm #1: Incentive Structure, No IncentiveActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will have no language about incentives.
Group V: RCT #4, Arm #2: Incentive Structure, Guarantee OnlyActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $25.
Group VI: RCT #4, Arm #3: Incentive Structure, Guarantee + Small LotteryActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $15 and have a 1 in 20 chance to receive $200.
Group VII: RCT #4, Arm #4: Incentive Structure, Mid Lottery OnlyActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 20 chance to receive $500.
Group VIII: RCT #5, Arm #5: Incentive Structure, Large Lottery OnlyActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 100 chance to receive $2500.
Group IX: RCT #2, Arm #2: Source of Contact, Research TeamActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the research team.
Group X: RCT #3, Arm #1: Framing Method, Appeal to AltruismActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will appeal to the person's altruism, for example: "Research studies like this one often do not include enough Black individuals. If Black people are not included in research like this, then doctors have less information about how cardiovascular disease might affect them and how new treatments could be used to improve their health. Your participation in this research can help doctors better understand how to treat members of your community in the future."
Group XI: RCT #1, Arm #1: Contact Method, Text OnlyActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message via text message. This message will invite them to participate in the parent trial.
Group XII: RCT #1, Arm #2: Contact Method, Email OnlyActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message via email. This message will invite them to participate in the parent trial.
Group XIII: RCT #1, Arm #3: Contact Method, Email+TextActive Control1 Intervention
Potential participants in the parent trial will be randomized to receive a message via email and text message. This message will invite them to participate in the parent trial.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

American Heart Association

Collaborator

Trials
352
Recruited
6,196,000+

Emory University

Collaborator

Trials
1,735
Recruited
2,605,000+

Findings from Research

The way clinical trial results are presented, such as using relative risk reduction or absolute risk reduction, can significantly influence physicians' perceptions and intended practices, with 12 studies highlighting this effect.
However, the impact of framing is highly variable and can be diminished by factors like the risk of harm, doctors' biases, and their clinical experience, indicating that while framing matters, it does not consistently dictate clinical decisions.
The effects of information framing on the practices of physicians.McGettigan, P., Sly, K., O'Connell, D., et al.[2019]
Patients participating in a study using financial incentives to lower LDL cholesterol reported positive experiences, with 65% noting personal health improvements and 61% experiencing increased health awareness.
The majority of patients (71%) found financial incentives motivating, and the intervention had little negative impact on their relationship with primary care physicians, suggesting that such approaches can be socially acceptable and effective.
Patients' views of a behavioral intervention including financial incentives.Shea, JA., Adejare, A., Volpp, KG., et al.[2018]
Behavioral economics-based nudges significantly increased appointment scheduling rates for both Medicare wellness visits (13.0% vs. 9.7%) and Pap smears (2.9% vs. 1.6%) when compared to standard reminders, indicating that modifying communication can effectively enhance patient engagement.
The nudges also improved appointment completion rates for Pap smears (23.5% vs. 17.0%), while completion rates for Medicare wellness visits were similar between nudge and control groups, suggesting that the effectiveness of nudges may vary by type of preventive service.
Effects of Behavioral Economics-Based Messaging on Appointment Scheduling Through Patient Portals and Appointment Completion: Observational Study.Liang, SY., Stults, CD., Jones, VG., et al.[2022]

References

The effects of information framing on the practices of physicians. [2019]
Patients' views of a behavioral intervention including financial incentives. [2018]
Effects of Behavioral Economics-Based Messaging on Appointment Scheduling Through Patient Portals and Appointment Completion: Observational Study. [2022]
Effects of Messaging Framing on the Self-Management Activities and Self-Efficacies of Patients with Type 2 Diabetes Mellitus. [2023]
Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial. [2022]
Can positive expectations help to improve the learning of risk literacy? A cluster-randomized study in undergraduate medical students. [2022]
Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. [2019]
Effects of a methodological infographic on research participants' knowledge, transparency, and trust. [2022]
Participants' preference for type of leaflet used to feed back the results of a randomised trial: a survey. [2022]
Visualising harms in publications of randomised controlled trials: consensus and recommendations. [2023]
A program for health behavior change in a preventive cardiology center. [2007]
12.United Statespubmed.ncbi.nlm.nih.gov
Promoting adherence to physical activity among individuals with cardiovascular disease using behavioral counseling: A theory and research-based primer for health care professionals. [2021]
13.United Statespubmed.ncbi.nlm.nih.gov
The Use of Behavior Change Techniques and Theory in Technologies for Cardiovascular Disease Prevention and Treatment in Adults: A Comprehensive Review. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis. [2022]
15.United Statespubmed.ncbi.nlm.nih.gov
Making Healthy Choices Easier: Regulation versus Nudging. [2017]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security